175 related articles for article (PubMed ID: 36185590)
1. Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes.
Schulte C; Singh B; Theofilatos K; Sörensen NA; Lehmacher J; Hartikainen T; Haller PM; Westermann D; Zeller T; Blankenberg S; Neumann JT; Mayr M
J Mol Cell Cardiol Plus; 2022 Sep; 1():None. PubMed ID: 36185590
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.
Nestelberger T; Boeddinghaus J; Giménez MR; Lopez-Ayala P; Ratmann PD; Badertscher P; Wildi K; Wussler D; Koechlin L; Arslani K; Zimmermann T; Freese M; Rinderknecht T; Miró Ò; Martin-Sanchez FJ; Kawecki D; Geigy N; Keller D; Twerenbold R; Müller C;
Eur Heart J Acute Cardiovasc Care; 2022 Jan; 11(1):62-74. PubMed ID: 34195803
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction.
Nestelberger T; Boeddinghaus J; Lopez-Ayala P; Kaier TE; Marber M; Gysin V; Koechlin L; Sanchez AY; Giménez MR; Wussler D; Walter JE; Strebel I; Zimmermann T; Glarner N; Miró Ò; Martin-Sanchez FJ; Zehnder T; Twerenbold R; Keller DI; Mueller C;
JAMA Cardiol; 2021 Jul; 6(7):771-780. PubMed ID: 33881449
[TBL] [Abstract][Full Text] [Related]
4. Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction.
Rocheleau S; Eng-Frost J; Lambrakis K; Khan E; Chiang B; Wattchow N; Steele S; Lorensini S; Lehman SJ; Papendick C; Chew DP
Heart Lung Circ; 2023 Aug; 32(8):978-985. PubMed ID: 37225600
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.
Bormann J; Psyrakis DA; von Jeinsen B; Grün D; Elsner LK; Wolter JS; Weferling M; Diouf K; Kriechbaum S; Troidl C; Dörr O; Nef H; Hamm CW; Liebetrau C; Keller T
Int J Cardiol; 2020 Apr; 304():144-147. PubMed ID: 32008845
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
[TBL] [Abstract][Full Text] [Related]
8. Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
Kassem M; Ayala PL; Andric-Cancarevic T; Tajsic M; Vargas KG; Bendik D; Kaufmann C; Wojta J; Mueller C; Huber K
Int J Cardiol; 2024 May; 403():131879. PubMed ID: 38369132
[TBL] [Abstract][Full Text] [Related]
9. Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
Díaz-Garzón J; Sandoval Y; Smith SW; Love S; Schulz K; Thordsen SE; Johnson BK; Driver B; Jacoby K; Carlson MD; Dodd KW; Moore J; Scott NL; Bruen CA; Hatch R; Apple FS
Clin Chem; 2017 Jan; 63(1):415-419. PubMed ID: 27811209
[TBL] [Abstract][Full Text] [Related]
10. Differentiating type 1 and 2 acute myocardial infarctions using the N-terminal pro B-type natriuretic peptide/cardiac troponin T ratio.
Nowak RM; Jacobsen G; Christenson RH; Moyer M; Hudson M; McCord J
Am J Emerg Med; 2018 Oct; 36(10):1849-1854. PubMed ID: 30007549
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
[TBL] [Abstract][Full Text] [Related]
12. A Biomarker Model to Distinguish Types of Myocardial Infarction and Injury.
Neumann JT; Weimann J; Sörensen NA; Hartikainen TS; Haller PM; Lehmacher J; Brocks C; Tenhaeff S; Karakas M; Renné T; Blankenberg S; Zeller T; Westermann D
J Am Coll Cardiol; 2021 Aug; 78(8):781-790. PubMed ID: 34412811
[TBL] [Abstract][Full Text] [Related]
13. Pseudo-targeted metabolic profile differences between emergency patients with type 1 and type 2 myocardial infarction diagnosed by optical coherence tomography.
Wang J; Li Z; Yang G; Fang C; Yin Y; Zheng Z; Wang H; Fang S; Dai J; Wang S; Yang S; Yu B
Clin Chim Acta; 2024 Feb; 554():117745. PubMed ID: 38185283
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.
White K; Kinarivala M; Scott I
BMJ Open; 2022 Feb; 12(2):e055755. PubMed ID: 35177458
[TBL] [Abstract][Full Text] [Related]
15. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.
Sandoval Y; Smith SW; Sexter A; Schulz K; Apple FS
Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):62-69. PubMed ID: 29979092
[TBL] [Abstract][Full Text] [Related]
16. Causes of Elevated Cardiac Troponins in the Emergency Department and Their Associated Mortality.
Meigher S; Thode HC; Peacock WF; Bock JL; Gruberg L; Singer AJ
Acad Emerg Med; 2016 Nov; 23(11):1267-1273. PubMed ID: 27320126
[TBL] [Abstract][Full Text] [Related]
17. Type 1 or Type 2 Myocardial Infarction in Patients with a History of Coronary Artery Disease: Data from the Emergency Department.
Putot A; Jeanmichel M; Chagué F; Avondo A; Ray P; Manckoundia P; Zeller M; Cottin Y
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31810178
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of patients with type 2 myocardial infarction.
Neumann JT; Sörensen NA; Rübsamen N; Ojeda F; Renné T; Qaderi V; Teltrop E; Kramer S; Quantius L; Zeller T; Karakas M; Blankenberg S; Westermann D
Eur Heart J; 2017 Dec; 38(47):3514-3520. PubMed ID: 29020401
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of high sensitivity cardiac troponin T (hs-cTnT) in dialysis patients with myocardial infarction.
Zhao K; Shen B; Wei H; Lu R; Liu Y; Xu C; Cai H; Huang Y; Li P; Ye X; Li Y
Front Cardiovasc Med; 2023; 10():1278073. PubMed ID: 38188256
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
